David Carroll - Dec 9, 2021 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role: SVP, CFO and Treasurer
Signature: /s/ Todd Anderman, as Attorney-in-Fact for David F. Carroll
Stock symbol: ISEE
Transactions as of: Dec 9, 2021
Transactions value $: -$52,517
Form type: 4
Date filed: 12/13/2021, 06:49 PM
Next filing: Dec 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise		+10K	+11.86%		94.3K	Dec 9, 2021	Direct	F1, F2
transaction	ISEE	Common Stock	Sale	-$52.5K	-3.61K	-3.83%	$14.53	90.7K	Dec 10, 2021	Direct	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Restricted Stock Units	Options Exercise	$0	-10K	-33.33%	$0.00	20K	Dec 9, 2021	Common Stock	10K		Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2	This total includes 2,144 shares acquired by the Reporting Person on March 15, 2021, and 2,006 shares acquired by the Reporting Person on September 15, 2021, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F3	Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 9, 2021.
F4	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $14.35 to $14.74 on December 10, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F5	On December 9, 2019, the Reporting Person was granted an award of 40,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.